Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 11 studies | 27% ± 10% | |
non-classical monocyte | 11 studies | 28% ± 11% | |
conventional dendritic cell | 8 studies | 26% ± 14% | |
microglial cell | 8 studies | 22% ± 7% | |
dendritic cell | 8 studies | 27% ± 11% | |
macrophage | 8 studies | 23% ± 7% | |
monocyte | 5 studies | 25% ± 2% | |
myeloid cell | 4 studies | 22% ± 6% | |
brush cell | 3 studies | 24% ± 2% |
Insufficient scRNA-seq data for expression of PLCB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 6234.22 | 578 / 578 | 96% | 11.00 | 1105 / 1155 |
intestine | 95% | 2189.07 | 919 / 966 | 86% | 5.99 | 453 / 527 |
breast | 85% | 1198.39 | 389 / 459 | 95% | 7.47 | 1060 / 1118 |
brain | 74% | 1234.39 | 1968 / 2642 | 99% | 14.95 | 696 / 705 |
stomach | 81% | 880.73 | 290 / 359 | 90% | 5.95 | 258 / 286 |
prostate | 91% | 1398.94 | 223 / 245 | 79% | 3.48 | 397 / 502 |
uterus | 80% | 811.08 | 136 / 170 | 90% | 6.06 | 413 / 459 |
thymus | 83% | 1134.39 | 542 / 653 | 84% | 9.69 | 506 / 605 |
bladder | 86% | 1569.43 | 18 / 21 | 76% | 6.04 | 382 / 504 |
kidney | 69% | 1024.54 | 61 / 89 | 91% | 10.01 | 817 / 901 |
adrenal gland | 95% | 1510.66 | 245 / 258 | 57% | 2.67 | 132 / 230 |
esophagus | 78% | 795.88 | 1125 / 1445 | 74% | 4.08 | 136 / 183 |
liver | 76% | 853.31 | 172 / 226 | 57% | 3.07 | 232 / 406 |
pancreas | 30% | 305.88 | 97 / 328 | 93% | 12.44 | 166 / 178 |
skin | 27% | 222.92 | 489 / 1809 | 92% | 13.54 | 436 / 472 |
ovary | 38% | 330.38 | 69 / 180 | 80% | 5.41 | 344 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.90 | 29 / 29 |
spleen | 100% | 18356.89 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.30 | 1 / 1 |
peripheral blood | 99% | 13651.28 | 924 / 929 | 0% | 0 | 0 / 0 |
adipose | 96% | 2113.33 | 1152 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 11.69 | 70 / 80 |
tonsil | 0% | 0 | 0 / 0 | 87% | 7.29 | 39 / 45 |
heart | 72% | 864.26 | 623 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 69% | 1050.10 | 927 / 1335 | 0% | 0 | 0 / 0 |
muscle | 9% | 65.10 | 74 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0001580 | Biological process | detection of chemical stimulus involved in sensory perception of bitter taste |
GO_0046488 | Biological process | phosphatidylinositol metabolic process |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0051209 | Biological process | release of sequestered calcium ion into cytosol |
GO_0048015 | Biological process | phosphatidylinositol-mediated signaling |
GO_0016042 | Biological process | lipid catabolic process |
GO_0098992 | Cellular component | neuronal dense core vesicle |
GO_0005829 | Cellular component | cytosol |
GO_0031680 | Cellular component | G-protein beta/gamma-subunit complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0004629 | Molecular function | phospholipase C activity |
GO_0031683 | Molecular function | G-protein beta/gamma-subunit complex binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0005543 | Molecular function | phospholipid binding |
GO_0004435 | Molecular function | phosphatidylinositol phospholipase C activity |
Gene name | PLCB2 |
Protein name | Phospholipase C beta 2 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-2) (Phospholipase C-beta-2) (PLC-beta-2) PLCB2 protein (Phospholipase C beta 2) (Phospholipase C, beta 2) |
Synonyms | hCG_38956 |
Description | FUNCTION: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. . |
Accessions | ENST00000456256.6 [Q00722-3] ENST00000559671.5 H0YKR9 Q00722 Q9BVT6 ENST00000543785.3 ENST00000559618.1 ENST00000557821.5 [Q00722-2] ENST00000260402.8 [Q00722-1] H0YNI4 |